Casanova, Michela

Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study

Geoerger, B., Zwaan, C. M., Marshall, L. V., Michon, J., Bourdeaut, F., Casanova, M., Corradini, N., Rossato, G., Farid-Kapadia, M., Shemesh, C. S., et al. (2020) · The Lancet Oncology

Cancer Immunotherapy and BiomarkersCAR-T cell therapy research

Cited by 171

How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears?

Casanova, M., Pagani Bagliacca, E., Silva, M., Patriarca, C., Veneroni, L., Clerici, C. A., Spreafico, F., Luksch, R., Terenziani, M., Meazza, C., et al. (2020) · Pediatric Blood & Cancer

COVID-19 and Mental HealthCOVID-19 and healthcare impacts

Cited by 104

Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study

Gaspar, N., Venkatramani, R., Hecker-Nolting, S., Melcon, S. G., Locatelli, F., Bautista, F., Longhi, A., Lervat, C., Entz-Werle, N., Casanova, M., et al. (2021) · The Lancet Oncology

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments

Cited by 89

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆

Gaspar, N., Campbell-Hewson, Q., Gallego Melcon, S., Locatelli, F., Venkatramani, R., Hecker-Nolting, S., Gambart, M., Bautista, F., Thebaud, E., Aerts, I., et al. (2021) · ESMO Open

Sarcoma Diagnosis and TreatmentOvarian cancer diagnosis and treatment

Cited by 59

Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas

Pearson, A. D., Gaspar, N., Janeway, K., Campbell-Hewson, Q., Lawlor, E. R., Copland, C., Karres, D., Norga, K., Benzaghou, F., Weiner, S., et al. (2022) · European Journal of Cancer

Sarcoma Diagnosis and TreatmentPharmaceutical studies and practices

Cited by 22

Being diagnosed with a rhabdomyosarcoma in the era of artificial intelligence: whom can we trust?

Clerici, C. A., Bernasconi, A., Lasalvia, P., Bisogno, G., Milano, G. M., Trama, A., Chiaravalli, S., Bergamaschi, L., Casanova, M., Massimino, M., et al. (2024) · Pediatric Blood & Cancer

Artificial Intelligence in Healthcare and EducationHealth Literacy and Information Accessibility

Cited by 8